Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The amount of potential reward is not clear.The low end estimates on that reward

Licensing is going to be very difficult at this point given the uncertainty that the ITC decision has brought about. Remember, the NDCA victory is a district court ruling. The ITC was a federal one, which had the potential of greater leverage against the potential infringers. There are now two conflicting claim constructions.

If I'm a company that is being pursued to sign a license, why would I not wait it out if there's no danger of an injunction? Unless I'm the biggest fish in the ocean, why would I think TPL has the resources to come after me?

In other words, TPL needs to suck it up and go pursue another target in court. I just don't think any of the smaller fish will cave at this point.

Share
New Message
Please login to post a reply